Regulation of oligodendrocyte differentiation and myelination by sigma-1 receptors: A possible link to schizophrenia

被引:0
|
作者
Hayashi, T.
Su, T. P.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S141 / S141
页数:1
相关论文
共 50 条
  • [31] Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor
    Dhir, Ashish
    Kulkarni, S. K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 (04) : 387 - 394
  • [32] Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?
    Hashimoto, Kenji
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 470 - 474
  • [33] Development of Radiolabeled Probes Directed against Sigma-1 Receptors
    Ogawa, Kazuma
    Masuda, Ryohei
    Shiba, Kazuhiro
    BUNSEKI KAGAKU, 2017, 66 (06) : 403 - 411
  • [34] Sigma-1 Receptors Fine-Tune the Neuronal Networks
    Tsai, Shang-Yi Anne
    Su, Tsung-Ping
    SIGMA RECEPTORS: THEIR ROLE IN DISEASE AND AS THERAPEUTIC TARGETS, 2017, 964 : 79 - 83
  • [35] Interaction of 2-mercaptobenzimidazole derivatives with sigma-1 receptors
    E. V. Ryaskina
    M. V. Voronin
    S. B. Seredenin
    Pharmaceutical Chemistry Journal, 2012, 46 : 334 - 336
  • [36] Sigma-1 receptors and animal studies centered on pain and analgesia
    Davis, Mellar P.
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (08) : 885 - 900
  • [37] Interaction of 2-mercaptobenzimidazole derivatives with sigma-1 receptors
    Ryaskina, E. V.
    Voronin, M. V.
    Seredenin, S. B.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2012, 46 (06) : 334 - 336
  • [38] Sigma-1 Receptors Promote Lymphatic Endothelial Barrier Function
    Abdelmaboud, Salma
    Motawe, Zeinab
    Breslin, Jerome
    FASEB JOURNAL, 2020, 34
  • [39] ALLOSTERIC MODULATOR OF SIGMA-1 RECEPTORS ENHANCE COGNITION AND MEMORY
    Zvejniece, L.
    Vavers, E.
    Svalbe, B.
    Domracheva, I.
    Vorona, M.
    Veinberg, G.
    Kalvinsh, I.
    Dambrova, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 177 - 178
  • [40] Sigma-1 Receptors: Potential Targets for the Treatment of Substance Abuse
    Robson, Matthew J.
    Noorbakhsh, Bahar
    Seminerio, Michael J.
    Matsumoto, Rae R.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (07) : 902 - 919